Aurinia Pharmaceuticals AUPH Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's accumulated depreciation?
- Aurinia Pharmaceuticals (AUPH) reported accumulated depreciation of $3.28M in Q1 2026.
- How has Aurinia Pharmaceuticals's accumulated depreciation changed year-over-year?
- Aurinia Pharmaceuticals's accumulated depreciation increased by 21.9% year-over-year, from $2.69M to $3.28M.
- What is the long-term trend for Aurinia Pharmaceuticals's accumulated depreciation?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's accumulated depreciation has grown at a 77.5% compound annual growth rate (CAGR), from $179K to $3.15M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.